Potential sources of increased iron in the substantia nigra of parkinsonian patients.

Potential sources of increased iron in the substantia nigra of parkinsonian patients.

Item
http://www.wikidata.org/entity/Q33259219
Morphological and metabolic changes in the nigro-striatal pathway of synthetic proteasome inhibitor (PSI)-treated rats: a MRI and MRS studyIron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseasesA novel role for glyceraldehyde-3-phosphate dehydrogenase and monoamine oxidase B cascade in ethanol-induced cellular damageIs R2* a new MRI biomarker for the progression of Parkinson's disease? A longitudinal follow-up.Iron in chronic brain disorders: imaging and neurotherapeutic implications.Glyceraldehyde-3-phosphate dehydrogenase-monoamine oxidase B-mediated cell death-induced by ethanol is prevented by rasagiline and 1-R-aminoindan.Ethanol increases TIEG2-MAO B cell death cascade in the prefrontal cortex of ethanol-preferring rats.Neuromelanin is an immune stimulator for dendritic cells in vitro.The role of environmental exposures in neurodegeneration and neurodegenerative diseases.Subchronic polychlorinated biphenyl (Aroclor 1254) exposure produces oxidative damage and neuronal death of ventral midbrain dopaminergic systems.Stress chaperone mortalin regulates human melanogenesis.Chelators in the treatment of iron accumulation in Parkinson's disease.T2* and FSE MRI distinguishes four subtypes of neurodegeneration with brain iron accumulation.Pooled analysis of iron-related genes in Parkinson's disease: association with transferrin.Biomarkers for prediction and targeted prevention of Alzheimer's and Parkinson's diseases: evaluation of drug clinical efficacy.A novel iron (II) preferring dopamine agonist chelator D-607 significantly suppresses α-syn- and MPTP-induced toxicities in vivo.Brain iron concentrations in regions of interest and relation with serum iron levels in Parkinson disease.
P2860

Potential sources of increased iron in the substantia nigra of parkinsonian patients.

Item
http://www.wikidata.org/entity/Q33259219
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Potential sources of increased iron in the substantia nigra of parkinsonian patients.
@ast
Potential sources of increased iron in the substantia nigra of parkinsonian patients.
@en
type
label
Potential sources of increased iron in the substantia nigra of parkinsonian patients.
@ast
Potential sources of increased iron in the substantia nigra of parkinsonian patients.
@en
prefLabel
Potential sources of increased iron in the substantia nigra of parkinsonian patients.
@ast
Potential sources of increased iron in the substantia nigra of parkinsonian patients.
@en
P1433
P1476
P2093
P304
P31
P433
P577
P698
P921
P1433
P1476
Potential sources of increased iron in the substantia nigra of parkinsonian patients.
@en
P2093
P304
P31
P433
P577
P698
P921